The acute phase of Peyronie’s Disease is the initial, inflammatory period of the condition. It is during this phase that the patient notices the first symptoms and should preferably seek specialized care. 

During the acute phase of Peyronie’s Disease, a man may notice changes in the penis, such as the onset of curvature and pain during erection. These changes may affect sexual function and the patient’s self-confidence.

Although each case evolves differently, specialized assessment makes it possible to determine the stage of the disease, monitor its progression and identify the most appropriate therapeutic approach.

What is the acute phase of Peyronie’s Disease?

The acute phase of Peyronie’s Disease is also called the active or inflammatory phase. It is the period in which symptoms may still be evolving, with the possibility of penile pain and the onset or worsening of penile curvature, as well as other penile deformities.

At this stage, fibrous plaques initially form in the tunica albuginea, a structure that surrounds the corpora cavernosa of the penis. These plaques may interfere with tissue elasticity during erection, contributing to pain, curvature, narrowing, shortening and difficulty during sexual activity.

The duration of the acute phase may vary from patient to patient. In some cases, symptoms stabilize over months. In others, curvature may progress or functional impairment may worsen.

Main symptoms of the acute phase of Peyronie’s Disease

Early signs may be subtle. Early identification helps the specialist determine whether there is active inflammation, progression of penile fibrosis or functional impact.

• Penile pain, especially during erection;
• Recent penile curvature or worsening of pre-existing curvature;
• A palpable nodule, thickening or plaque in the penis;
• Penile shortening or the perception of lost length;
• Penile narrowing or constriction;
• Changes in rigidity and difficulty maintaining an erection;
• Difficulty, discomfort or limitation during sexual activity.

 

It is important to emphasize: not all patients have the same symptoms. Therefore, any change in sexual health should be assessed promptly.

How is the diagnosis made?

Diagnosis of Peyronie’s Disease in the acute phase begins with the medical history. The specialist assesses when symptoms began, whether curvature is progressing, whether pain occurs during erection and whether there is an impact on sexual function.

Physical assessment makes it possible to identify plaques, areas of thickening, changes in penile caliber and signs of penile deformity.

In some cases, a penile Doppler ultrasound may be useful to obtain more details. The examination may contribute to the assessment of plaques, calcifications, fibrosis, blood flow and factors associated with erectile dysfunction.

When should specialized care be sought?

Specialized consultation is recommended when the patient notices the first symptoms. Early follow-up may allow monitoring of progression, evaluation of the response to potential therapeutic measures and adjustment of the approach as needed.

It is important to emphasize that seeking an assessment does not necessarily mean starting an immediate intervention or following a single protocol.

Each case should be analyzed individually, considering the intensity of symptoms, degree of curvature, presence of pain and erectile function and impact on sexual life.

The main purpose of the consultation is to determine the stage of the condition, monitor potential changes and define a strategy proportionate to the clinical presentation.

For some patients, follow-up alone may be indicated. For others, medications and complementary treatments, such as devices and specific exercises, may be considered.

Treatment options for the acute phase of Peyronie’s Disease

Treatment for the acute phase of Peyronie’s Disease depends on clinical characteristics, symptom progression and functional impact.

In some cases, clinical follow-up may be sufficient to observe the condition. This makes it possible to determine whether curvature is stable, whether pain is decreasing or whether there are signs of progression, as well as to adjust the therapeutic strategy when needed.

When there is significant pain, inflammation or progression of curvature, individualized treatments may be considered, such as:

• Anti-inflammatory medications that may help control pain;
• Medications aimed at erectile function may be considered when associated erectile dysfunction is present;
• Penile traction therapies or vacuum devices to stimulate penile tissues;
• Psychological or sexological support, which may be useful when the condition affects self-esteem, relationships or sexual function quality.

 

The therapeutic approach should be individualized and balance the expected benefits, the limitations of available scientific evidence and the patient’s goals.

In certain cases, treatment may help control symptoms, monitor progression and improve erectile function, but the most appropriate strategy always depends on specialized assessment, clinical characteristics and the patient’s expectations.

What is the role of early follow-up?

Early follow-up in Peyronie’s Disease may allow monitoring of progression, evaluation of response to potential therapeutic measures and adjustment of the strategy as needed. This does not mean that it is possible to reverse the curvature or resolve the condition.

It means that, by seeking care in an initial presentation of Peyronie’s Disease, the patient can be followed more closely, with documentation of progression, assessment of erectile function and identification of factors that may influence the disease’s course.

Receiving specialized guidance early may be important for aligning expectations, understanding possible changes in sexual activity and adapting the therapeutic approach to each patient’s needs.

Specialized assessment for Peyronie’s Disease

Individualized follow-up of patients with Peyronie’s Disease in the acute or stable phase is important to define a strategy appropriate to each patient’s needs.

Specialized assessment makes it possible to align expectations, understand the available therapeutic options and make informed decisions about the best approach for each case.